Stay updated on Nivolumab Dose Optimization Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Dose Optimization Clinical Trial page.

Latest updates to the Nivolumab Dose Optimization Clinical Trial page
- Check6 days agoChange DetectedRemoved MedlinePlus Genetics topic on lung cancer, reducing coverage of that specific genetic/medical topic.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded a new MedlinePlus Genetics topic on Lung cancer to the page, expanding core content related to genetics and cancer.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

- Check27 days agoChange DetectedAdd: new version label v3.1.0. Remove: old version label v3.0.2 and the topic tag 'Lung cancer' under MedlinePlus Genetics.SummaryDifference0.2%

- Check35 days agoChange DetectedAdded MedlinePlus Genetics topic on Lung cancer to the page, expanding core content related to genetics and oncology.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page is updated to v3.0.2: it removes the Lung cancer topic under MedlinePlus Genetics and the Back to Top link, replacing the previous v3.0.1 tag with v3.0.2.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Dose Optimization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Dose Optimization Clinical Trial page.